为您找到"
hlp3
"相关结果约100,000,000个
Dysbetalipoproteinemia, also known as familial dysbetalipoproteinemia (FD), hyperlipoproteinemia type III (HLP3), or broad β disease, is a genetic lipid disorder characterized by increased accumulation of triglyceride-rich remnant lipoproteins. The accumulation of lipoproteins is due to impaired remnant clearance. Most patients with dysbetalipoproteinemia are homozygous for the apolipoprotein ...
We also observed enrichment of TG in both HDL and LDL in HLP3 patients (), suggesting an abnormal lipid composition for these lipoprotein particles too.This was further analyzed in Figure 1 by examining the ratio of cholesterol and TG in the major lipoprotein fractions. A much greater fraction of plasma TC, almost 90% on average, was present in the non-HDL fraction for HLP3 patients ().
HLP3 prevalence estimates varied substantially across UC criteria and between UC and apoB methods. Among various UC critreria, relatively minor changes in VLDL-C/TG ratio cut-points appear to have a noticable effect on prevalence estimates, such as in this case where decreasing the threshold from 0.3 to0.25 in UC criteria 2 increases prevalence ...
Dysbetalipoproteinemia, also known as familial dysbetalipoproteinemia (FD), hyperlipoproteinemia type III (HLP3), or broad β disease, is a genetic lipid disorder characterized by increased accumulation of triglyceride-rich remnant lipoproteins. The accumulation of lipoproteins is due to impaired rem …
Background: Hyperlipoproteinemia Type III (HLP3), also known as dysbetalipoproteinemia, is defined by cholesterol and triglyceride (TG) enriched remnant lipoprotein particles (RLP). The gold standard for diagnosis requires demonstration of high remnant lipoprotein particle cholesterol (RLP-C) by serum ultracentrifugation (UC), which is not readily available in daily practice.
Hyperlipoproteinemia type 3 (HLP3) is caused by impaired removal of triglyceride-rich lipoproteins (TGRL) leading to accumulation of TGRL remnants with abnormal composition. High levels of these remnants, called β-VLDL, promote lipid deposition in tuberous xanthomas, atherosclerosis, premature coron …
Introduction: Dysbetalipoproteinaemia (HLP3) is a genetic disorder of excess lipoprotein remnants that powerfully promotes premature atherogenic cardiovascular disease. Prior smaller studies using electrophoresis and ultracentrifugation (UC) estimated a prevalence of 0.1-0.4%. Hypothesis: We hypothesized that current prevalence of HLP3 in U.S. adults with a newly described apolipoprotein B ...
The sole population-based study of the prevalence of type III HLP is the Lipid Research Clinics Prevalence Study. 21 This involved 10 well-defined North American populations studied 1972-1976. Type III HLP was diagnosed when VLDL with beta electrophoretic mobility was present and the ratio of VLDL cholesterol (mg/dL) to total plasma TG (mg/dL) was >0.3.
Hyperlipoproteinemia type 3 (HLP3) is caused by impaired removal of triglyceride-rich lipoproteins (TGRL) leading to accumulation of TGRL remnants with abnormal composition. High levels of these remnants, called β-VLDL, promote lipid deposition in tuberous xanthomas, atherosclerosis, premature coronary artery disease, and early myocardial infarction. Recent genetic and molecular studies ...
HLP3 patients (N = 115) were used to develop a regression analysis for VLDL-C (A) and VLDL-TG (B) with the indicated input variables that include apoB. Solid lines are the linear fit for the indicated regression equation. Dashed lines are the line of identity. Results are color-coded by TG levels with the value in the legend indicating the ...